NovoCure Limited Announces Launch of Initial Public Offering
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 9/1/2026
- Wall Street closes lower as oil prices jump, indexes notch monthly gains
- The Warsh pivot markets didn't expect
- Oil settles up by more than 2.5% as US and Iran resume military attacks
- Energy stocks rally as fresh U.S.-Iran attacks drive oil prices higher
- BofA turns S&P 500 signals from red to yellow: What to buy now
NovoCure Limited (NVCR) IPO Opens Lower
October 2, 2015 10:43 AM EDTToday's IPO for NovoCure Limited (Nasdaq: NVCR) opened for trading at $20.16 after pricing 12,500,000 shares of its common stock at $22, below the $23-$24 revised IPO range. Shares last traded at $19.
J.P. Morgan Securities LLC, Deutsche Bank Securities and Evercore Group... More
NovoCure (NVCR) Launches 12.5M Common Stock IPO
October 2, 2015 6:09 AM EDTNovoCure Limited (Nasdaq: NVCR), a commercial stage oncology company pioneering a novel therapy for solid tumors, announced today the launch of its initial public offering of 12,500,000 shares of its common stock, including 7,500,000 shares to be sold by NovoCure Limited and 5,000,000 shares to be sold by selling shareholders. The initial public offer is currently expected to be between $26 and $29 per share. The underwriters for the offering will... More
